- Explain to interested patients that although this study did not find a link, some case reports have suggested that atypical fractures of the femur may be more common in patients treated with bisphosphonates, the most common drugs for treating osteoporosis.
- Explain that the FDA has begun a formal safety inquiry into this potential risk, but it has emphasized that it has not yet found evidence to suggest that physicians or patients should avoid these drugs.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.